HOME >> BIOLOGY >> NEWS
Findings link disease specific anitbodies to activation of T cells for the first time

Torrance, Calif. (January 25, 2002) - Harbor-UCLA Research & Education Institute (REI) announced new findings indicating that antibodies specific to Graves disease bind to cell surface receptors. These are distinct from thyroid-stimulating hormone (TSH) receptors. This interaction leads to activation of key genes and T cell activation. It is believed that antibody/receptor complex initiates a cascade of events culminating in T cell activities and thyroid growth. This research, conducted by principal REI investigator Terry J. Smith, MD and collaborators at Boston University School of Medicine, Boston was published recently in The Journal of Immunology, 168:942-950,2002.

What is exciting about these findings is that now, for the first time, we can tie together pathogenic antibodies in Graves disease with T cell activation, said Dr. Smith, Chief, Division of Molecular Medicine, Department of Medicine at Harbor-UCLA Medical Center. This holds promise for future research to learn how to turn off the expression, thereby eradicating the disease state. Graves disease is often associated with profound metabolic derangements and potentially site-threatening changes in the tissues around the eye, he added.

Dr. Smith and his collaborator, William Cruikshank, PhD at Boston University School of Medicine have been studying the pathogenesis of inflammation associated with many conditions, including rheumatoid arthritis, Graves disease, and lupus. This research group has recently identified a number of potential pathways that may be utilized by lymphocyte derived cytokines in driving the tissue remodeling that occurs in Graves disease. Dr. Smith and his associates have found that fibroblasts from the orbital connective tissue (eye area) differ from fibroblasts found in other parts of the body. The orbital fibroblasts appear to be particularly susceptible to inflammatory reactions. Fibroblasts are highly specialized cells and react differentl
'"/>

Contact: Barbara T. Kerr
bkerr@rei.edu
310-222-2820
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
24-Jan-2002


Page: 1 2

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. Findings redefine mechanism of action of RNA helicase enzymes
3. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
4. Findings could aid efforts to harness nature for making drugs
5. Findings offer clue to how molecule can both stimulate, suppress cell growth
6. Findings offer further understanding about growth and development in young male gymnasts
7. Findings in frog oocytes may help study of chromosome physiology
8. Findings aid understanding of neurodegenerative diseases
9. Findings show exceptional longevity runs in families
10. Findings give insight into how colon cells transform into precancerous polyps
11. Findings conclude sustained caffeine intake negates the benefits of creatine supplements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/7/2018)... ... September 05, 2018 , ... Following up on the launch ... year, IPS-Integrated Project Services, LLC and G-CON Manufacturing have successfully designed and delivered ... solution provides a pre-fabricated modular cleanroom infrastructure for the drug manufacturers’ requirements for ...
(Date:9/1/2018)... ... ... Ben Lecomte is hard at work on his second ocean crossing. After becoming the first ... from Tokyo to San Francisco, churning his limbs eight hours a day in the cold ... expedition of its kind, The Swim is far more than just an extreme sport. Besides ...
(Date:8/31/2018)... Wisc. (PRWEB) , ... August 30, 2018 , ... ... measure inhibitor residence times as a component of drug discovery programs. Longer-target engagement ... these residence times are low throughput, require expensive instrumentation, or require the alteration ...
Breaking Biology News(10 mins):
(Date:9/15/2018)... ... 2018 , ... Nationally recognized public accounting and consulting firm Cherry Bekaert ... the Firm’s Nashville practice, on her appointment to Launch Tennessee’s Board of ... Managing Partner of the Firm’s Nashville practice in December 2017 . In this role, ...
(Date:9/12/2018)... ... 2018 , ... NDA Partners Chairman Carl Peck, MD, announced ... Regulatory Affairs and Quality Systems at WellDoc, Inc., has joined the firm as ... Systems at WellDoc, Inc., she conducted quality control and supplier audits, led inspections ...
(Date:9/7/2018)... (PRWEB) , ... September 06, 2018 , ... Akadeum Life ... has spent his career as an executive and leader of numerous biotech companies. ... cell therapy and biologics company acquired by Thompson Street Capital in St. Louis, MO. ...
(Date:8/29/2018)... Mass. (PRWEB) , ... August 28, 2018 , ... ... announcing the full lineup of talks for NAVIGATE2018 . , Ryan Ward, ... NAVIGATE2018 , Cognition’s annual user conference. An experienced engineer and manager with Zimmer Biomet ...
Breaking Biology Technology:
Cached News: